<DOC>
	<DOCNO>NCT02586168</DOCNO>
	<brief_summary>The purpose study determine effect gemcabene insulin sensitivity define average glucose disposal rate .</brief_summary>
	<brief_title>The Effect Gemcabene Insulin Sensitivity Nondiabetic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Good health , determine medical history , physical examination , EKG clinical laboratory assessment Males ; female non‐reproductive potential Obesity Non‐diabetic Use medication consider unacceptable clinical investigator 14‐day period start Day 1 . Hormone Replacement Therapy acceptable . Use lipid‐lowering agent ( niacin , fibrates , statin ) 8 week screen Use anti‐diabetic medication Use steroid medication Donation blood plasma product participation another study 30 day prior Day 1 If female , pregnant , lactate childbearing potential ; History significant reaction fibrate lipid‐lowering agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Insulin Resistance</keyword>
	<keyword>Lipid Regulator</keyword>
</DOC>